Asia / JAPAN
To continue to view the full report
Buy this company's report, or subscribe to a plan.
Company Overview
Medikit Co., Ltd. engages in the manufacture and sale of medical equipment. It operates through the following divisions: Artificial Dialysis, and Intravenous Needles. The Artificial Dialysis division includes catheters used for artificial dialysis. The Intravenous Needles division manufactures and sells needles used in blood transfusion and anesthesia. The company was founded by Hiroaki Nakajima on June 15, 1973 and is headquartered in Tokyo, Japan.
Medikit Co., Ltd. engages in the manufacture and sale of medical equipment. It operates through the following divisions: Artificial Dialysis, and Intravenous Needles. The Artificial Dialysis division includes catheters used for artificial dialysis. The Intravenous Needles division manufactures and sells needles used in blood transfusion and anesthesia. The company was founded by Hiroaki Nakajima on June 15, 1973 and is headquartered in Tokyo, Japan.
Includes quarterly earnings and dividends.
Company Details
| Major Industry | Health Care Equipment & Services |
| Sub Industry | Surgical & Medical Instruments |
| Country | JAPAN |
| Employees | 994 |
| Reporting Unit | Billions |
| Primary Exchange | TYO |
| Instrument Type | Equity |
| Website | http://www.medikit.co.jp |
| Wright ID | C392KPNS4 |
Key Metrics
| Current price | $2,642.00 |
| Market cap | $38.25 B |
| P/E ratio | 12.25 |
| 52-week perf. | +0.9% |
| Common shares | 14.5 M |
| Closely held | 8.6 M |
| Share type | Common |
| Quality rating | DAB6 |
| Dividend yield | 3.79% |
Recent stock performance
| 1 Week | -1.0% |
| 4 Week | -4.7% |
| 13 Week | -4.1% |
Officers
| President | Yoji Kageyama (Rep) |
| Vice President | Takashi Nakajima |
Address
1-13-2 Yushima
BUNKYO-KU, Tokyo-to
JAPAN
113-0034
| Phone | n/a |
Quarterly Earnings & Dividends
Quarterly earnings and dividend history is not available for this company.
Try another report for annual statements, Wright Quality history or comparative analysis.